ClinConnect ClinConnect Logo
Search / Trial NCT06660914

Robotic Flexible Ureteroscopy Versus Standard Flexible Ureteroscopy for Renal Stones

Launched by CHINESE UNIVERSITY OF HONG KONG · Oct 25, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is comparing two methods for treating kidney stones: robotic flexible ureteroscopy and standard flexible ureteroscopy. Both procedures involve using a thin tube with a camera to remove stones from the kidneys, but one method uses robotic technology to assist the doctor. The goal of the study is to see which method is more effective and has better outcomes for patients.

To participate in this trial, you need to be at least 18 years old and able to give your consent. However, there are some criteria that might exclude you, such as having certain urinary tract problems, a high level of health issues that could complicate anesthesia, or having untreated infections. If you're interested in joining the study, you'll receive detailed information about the procedures and what to expect during your treatment, helping you make an informed decision about your care.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years old with informed consent
  • Being willing and able to provide written informed consent
  • Exclusion Criteria:
  • Patients with abnormal urinary tract (e.g. ileal conduit, neobladder, ureteric stricture)
  • American Society of Anesthesiologists (ASA) physical status classification system \>3
  • Untreated urinary tract infection
  • Renal stones \> 3cm in diameter

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Sheung Shui, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Chi Fai NG, MD

Principal Investigator

Chinese University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported